Day: January 3, 2024

BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 8, 2024 at 4:30 p.m. EST / 1:30 p.m. PST. HIL-214, HilleVax’s investigational virus-like particle (VLP) based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis, and the related ongoing Phase 2b study NEST-IN1 will be topics of discussion.Presentation details:  Date: Monday, January 8, 2024Time: 1:30 – 2:10 p.m. Pacific Standard Time (PST)Moderator: Eric Joseph, Ph.D.Location: Elizabethan C Room, Westin St. Francis Hotel, San FranciscoHilleVax Participant: Robert Hershberg,...

Accomplished Hawai‘i business leaders, Catherine Ngo and Ken Ota appointed as Independent DirectorsCatherine NgoCatherine NgoKen OtaKen OtaMAUI, Hawaii, Jan. 03, 2024 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) announced the appointment of two new Independent Directors to its Board, effective January 1, 2024: Catherine Ngo, a seasoned leader at the intersection of finance, technology, and law; and Maui native Ken Ota, a successful local entrepreneur with over 30 years of experience in the construction industry and water infrastructure. “Catherine and Ken embody esteemed leadership and we are honored to add them to our diverse slate of Directors. We look forward to their thoughtful guidance as we chart the course for a future of growth,” said Race Randle, CEO of Maui Land & Pineapple...

SAULT STE. MARIE, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today provided guidance for its fiscal third quarter ending December 31, 2023. Unless otherwise specified, all amounts are in Canadian dollars. Fiscal 2024 third quarter total steel shipments are expected to be around 515,000 tons and Adjusted EBITDA is expected to be in the range of $(10) million to breakeven. Michael Garcia, Algoma’s Chief Executive Officer commented, “Our operations ran in line with our expectations during the fiscal third quarter, with a heavy focus on seasonal maintenance that included completion of our annual basic oxygen furnace relining and other servicing across the steelworks. Due to...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor”) (TSXV: RZE) advises that, as a result of ongoing disputes with the operator of the Judy Creek Gas Plant, the operator continues to restrict access and will not process Razor’s Swan Hills natural gas production. As indicated in Razor’s press release on December 27, 2023, effective December 24th, 2023, a significant portion of Razor’s production was shut-in indefinitely. Management continues to estimate that approximately 1,110 boepd, including 626 bblpd of light oil and 387 bblpd of natural gas liquids, has been curtailed. Razor is exploring various commercial and legal options...

BATON ROUGE, La., Jan. 03, 2024 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST) (Business First), the parent company of b1BANK, today announced that it is scheduled to release fourth quarter 2023 earnings after market close on Tuesday, January 23, 2024. Executive management will host a conference call and webcast to discuss results on the same day (Tuesday, January 23, 2024) at 4:30 p.m. CDT. Interested parties may attend the call by dialing toll-free 1-800-715-9871 (North America only), conference ID 4061156, or asking for the Business First Bancshares conference call. The live webcast can be found at https://edge.media-server.com/mmc/p/gctma4g8. On the day of the presentation, the corresponding slide presentation will be available to view on the b1BANK website at https://www.b1bank.com/shareholder-info. About...

VIRGINIA CITY, Nev., Jan. 03, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) announces the Company’s fourth quarter 2023 Stakeholder Perception Analysis Report (the “Report”) which was compiled by Comstock’s investor relations firm, RB Milestone Group LLC (“RBMG”), and provides insight into Comstock’s operational milestones and stakeholder perceived strengths and weaknesses. The Report also includes a brief video recording of Comstock’s Executive Chairman and Chief Executive Officer, Corrado De Gasperis, and RBMG’s Managing Director, Trevor Brucato, reviewing and discussing the results. Click Here for Comstock’s 4Q23 Stakeholder Perception Analysis Report RBMG gathered the data from the investor survey during the period of October 26, 2023 (Comstock’s 3Q23 earnings call) to December 31, 2023 (the...

EDISON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced that an abstract highlighting its lead drug candidate, rencofilstat, will be presented at the 2024 NASH-TAG Conference, which is being held January 4-6, 2024, in Park City, Utah. Presentation Details Title: Hepatic Functional Improvement Detected by HepQuant DuO within 120 Days of Treatment with Rencofilstat in MASH Subjects with ≥F3 Fibrosis. Authors: SA Harrison, P Mayo, T Hobbs, C Zhao, C Canizares, R Foster, MP McRae, SM Helmke, and GT Everson Date: Saturday, January...